The effects of inhaled aztreonam on the cystic fibrosis lung microbiome

The effects of inhaled aztreonam on the cystic fibrosis lung microbiome

Abstract Background Aztreonam lysine for inhalation (AZLI) is an inhaled antibiotic used to treat chronic Pseudomonas aeruginosa infection in CF. AZLI improves lung function and quality of life, and reduces exacerbations-improvements attributed to its antipseudomonal activity. Given the extremely hi...

Full description

Bibliographic Details
Main Authors: Alya A. Heirali, Matthew L. Workentine, Nicole Acosta, Ali Poonja, Douglas G. Storey, Ranjani Somayaji, Harvey R. Rabin, Fiona J. Whelan, Michael G. Surette, Michael D. Parkins
Format: Article
Language:English
Published: BMC 2017-05-01
Series:Microbiome
Subjects:
Microbiota
AZLI
Inhaled antibiotics
Pseudomonas aeruginosa
Prevotella
Fusobacterium
Online Access:http://link.springer.com/article/10.1186/s40168-017-0265-7

Internet

http://link.springer.com/article/10.1186/s40168-017-0265-7

Similar Items